No Data
CITIC SEC (06030): CITIC SEC International provided a guarantee for the 70 million dollar notes issued by CSI MTN Limited.
CITIC SEC (06030) announced that its wholly-owned overseas subsidiary CITIC SEC International's subsidiary CSI ...
CITIC SEC: Initiates a "Buy" rating for SINOPHARM with a Target Price of 27 HKD.
CITIC SEC released a Research Report stating that it is initiating coverage on SINOPHARM (01099) with a "Buy" rating and a 9x PE for 2025, corresponding to a Target Price of 27 HKD. The report states that SINOPHARM is a leading enterprise in the domestic Pharmaceutical distribution industry, with its core Business of pharmaceutical distribution maintaining steady growth against the backdrop of increasing industry concentration; the company's medical instruments Sector is gradually increasing its share, actively introducing medical manufacturing Business while continuously expanding market coverage and cooperation channels, and laying out an edge in advanced medical instruments such as fluorescence endoscopes and imaging equipment. As regulatory impacts on the industry clear, the performance of the company's medical instruments Sector is expected to resume growth; retail
CITIC SEC: Maintain Ideal Autos-W "Buy" rating, Target Price 151 Hong Kong dollars.
CITIC SEC released a research report stating that it maintains a "Buy" rating for Li Auto-W (02015), bullish on the company's investment value, maintaining a target price of HKD 151 per share based on a 25X Non-GAAP P/E ratio. The company expects sales of 0.1587 million vehicles and revenue of 44.3 billion yuan in the fourth quarter of 2024, with a gross margin of 19.7% and a Non-GAAP net income of 4 billion yuan. The company's guidance for Q1 2025 is sales of 0.088-0.093 million vehicles. The company plans to launch an upgraded version of its existing models in May 2025, using new chips to enhance autonomous driving capabilities; and plans to introduce pure electric models in July and in the second half of the year.
Citic Securities Adjusts Price Target on Oracle to $186 From $214, Keeps Buy Rating
China Nerin Engineering to Offer 30 Million Shares in Shanghai IPO
Goldman Sachs: Downgraded the S&P 500 Index year-end target from 6,500 points to 6,200 points.
Goldman Sachs has lowered the target price for the S&P 500 Index at the end of 2025 from 6,500 points to 6,200 points, reflecting the adjustment of its fair forward PE valuation from 21.5 times to 20.6 times, a decrease of 4%. Meanwhile, the expected EPS for the index components has also been reduced, with the 2024 EPS expectation dropping from $268 to $262, and the 2025 expectation decreasing from $288 to $280. Goldman Sachs has cited concerns over economic growth and the recent significant drop in the Magnificent 7 as reasons for lowering the target level of the benchmark index for the US stock market. This signifies a corresponding forward evaluation.
